- Small practices
- Clinical social workers
Cost Performance Category
The CMS is adding five newly developed episode-based cost measures into the Cost performance category.
You Might Also Like
Also By This Author
The CMS is maintaining the current data completeness threshold at 70% for the 2022 and 2023 performance periods.
Redistributing Performance Category Weights for Small Practices
The CMS is finalizing the following performance category reweighting and redistribution policies for small practices to put more emphasis on the Improvement Activities performance category:
- When the Promoting Interoperability performance category is reweighted:
- The Quality performance category will be weighted at 40%;
- The Cost performance category will be weighted at 30%; and
- The Improvement Activities performance category will be weighted at 30%.
- When both the Cost and the Promoting Interoperability performance categories are reweighted:
- The Quality performance category will be weighted at 50%; and
- The Improvement Activities performance category will be weighted at 50%.
Under the existing policies, when both Quality and the Promoting Interoperability performance categories are reweighted, the Cost and Improvement Activities performance categories will be equally weighted at 50%.
MIPS Value Pathways (MVPs)
One of the seven MVPs starting with the 2023 performance period/2025 MIPS payment year is Advancing Rheumatology Patient Care, created by the ACR. Through this MVP, rheumatology providers can choose among quality measures relevant to rheumatology and improvement activities that have been vetted by rheumatology experts.
The table below lists the measures and activities that are finalized within the Advancing Rheumatology Patient Care MVP.
|Q111: Pneumococcal Vaccination Status for Older Adults||IA_AHE_3: Promote use of Patient-Reported Outcome Tools||Total Per Capita Cost (TPCC)|
|Q130: Documentation of Current Medications in the Medical Record||IA_BE_4: Engagement of patients through implementation of improvements in patient portal|
|Q176: Tuberculosis Screening Prior to First Course Biologic Therapy||IA_BE_15: Engagement of patients, family and caregivers in developing a plan of care|
|Q177: Rheumatoid Arthritis (RA): Periodic Assessment of Disease Activity||IA_BMH_2: Tobacco use|
|Q178: Rheumatoid Arthritis (RA): Functional Status Assessment||IA_BMH_4: Depression screening|
|Q180: Rheumatoid Arthritis (RA): Glucocorticoid Management||IA_EPA_1: Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient’s Medical Record|
|ACR12: Disease Activity Measurements for Patients with PsA||IA_EPA_2: Use of telehealth services that expand practice access|